Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
<b>Background</b>: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal absorption, enhances insulin sensi...
Saved in:
Main Authors: | Awad Alshahrani (Author), Ahmad Aljada (Author), Afshan Masood (Author), Muhammad Mujammami (Author), Assim A. Alfadda (Author), Mohthash Musambil (Author), Ibrahim O. Alanazi (Author), Mohammed Al Dubayee (Author), Anas M. Abdel Rahman (Author), Hicham Benabdelkamel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
by: Lina A. Dahabiyeh, et al.
Published: (2021) -
Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
by: Shereen M. Aleidi, et al.
Published: (2021) -
Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
by: Muhammad Mujammami, et al.
Published: (2023) -
Untargeted metabolomics reveals the impact of Liraglutide treatment on metabolome profiling and metabolic pathways in type-2 diabetes mellitus
by: Hicham Benabdelkamel, et al.
Published: (2024) -
Bicytopenia secondary to systemic oxalosis
by: Mansoor C Abdulla, et al.
Published: (2015)